17-year-old Indian swimmer banned 18 months for doping violation

A 17-year-old Indian swimmer has been removed from India’s swimming team for the upcoming Asian Games and suspended for 18 months after failing a doping test. The swimmer has not been formally named because he is a minor, though the Times of India and other domestic outlets report that the suspended swimmer’s twin brother is still on the Asian Games team. Only one swimmer fits that description.

The swimmer tested positive in February and The Swimming Federation of India withdrew his name from the Commonwealth Games roster and later the Asian Games roster. He tested positive for terbutaline, a beta-2 agonist commonly prescribed for asthma, emphysema, bronchitis, and other lung diseases, according to the Mayo Clinic.

According to the Times of India, he suffered from smoke inhalation and took the prescription with a doctor’s approval, but did not properly obtain a therapeutic use exemption (TUE). He listed the substance on his doping control form. A standard doping violation suspension is four years, reducible to two years if the panel believes the athlete did not intentionally dope, with further reductions based on a reasonable explanation.

An expedited hearing took place last week with the national swimming federation hoping for a dropped case so he could race in Japan later this month. He had qualified for two events at that meet. Both twin brothers have represented India internationally at junior meets, though results often confuse them due to similar names.

Analysis from a sports medicine perspective

Terbutaline, a beta-2 agonist, is banned in sports because it can improve respiratory function and thus enhance endurance performance. When used via inhalation for therapeutic purposes, it is usually allowed with a TUE. The error here is administrative: the athlete failed to complete the exemption process. Under competitive pressure and at a young age, a lack of understanding of TUE procedures is common. Based on my experience monitoring doping cases in Southeast Asia, similar mistakes occur frequently, especially among minors who rely on doctors or coaches without independently checking regulations.

The doping context in India

India, the world’s most populous country, is not a global sports superpower. At the 2026 Summer Olympics, it won only six medals, none gold. However, in recent years India has consistently led the world in anti-doping violations. This reflects a rapidly developing sports system where performance pressure and inconsistent anti-doping education lead to unfortunate cases. Some injuries are not in the muscles or tendons, but in how we perceive the problem. Here, the wound is a knowledge gap in regulations.

Impact on career and team

With an 18-month ban, this athlete will miss the upcoming Asian Games and possibly other major events. For a 17-year-old talent, this is a critical development period. The prolonged break can affect physical fitness, technique, and psychology. His twin brother still has the opportunity to compete, but the absence of his sibling may weaken relay events. In the transfer and selection market, injuries—whether physical or doping-related—are interrupters everyone pretends not to hear.

Lessons on the TUE process

This case highlights the importance of obtaining a therapeutic use exemption correctly. If the athlete or his medical team had followed proper procedures, the outcome could have been different. It demonstrates that elite sport demands not only physical and technical ability but also regulatory knowledge. Data can lie, but it never forgets—every administrative mistake leaves a trace. Before blaming the athlete, ask whether the system equipped him with enough knowledge to protect himself.

The Asian Games will proceed without this young talent, but this may serve as a wake-up call for Indian sports: more investment in anti-doping education, especially for young athletes, is needed. The body does not need anyone’s consent, but the rules always require compliance.